Approx. Rs 300 / StripeGet Latest Price
Product BrochureProduct Details:| Strength | 500 mg |
| Brand | Biocon |
| Country of Origin | Made in India |
| Manufactured By | Biocon Ltd |
| Drug Name | Mycophenolate |
| Composition | Mycophenolate |
| Company | Biocon |
| Active Drug | Mycophenolate |
| Usage/Application | Personal |
| Packaging Size | Box |
| Packaging Type | Strips |
| Dose/Strength | 500mg/360mg |
Additional Information:
Approx. Rs 2,615 / PieceGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 1 Piece |
| Strength | 3.75 mg |
| Dose Schedule | Monthly |
| Brand | LURIDE DEOPT 3.75 MG INJ |
| Manufacturer | SUN PHARMA |
| Packaging Size | 2 ml |
| Shelf Life | should not be self-administered |
| Storage Instructions | Store at temperature not exeeding 25*C,protected from light Do not freez. |
Additional Information:
Approx. Rs 1,700 / BottleGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 10 Bottle |
| Strength | 100 mg |
| Brand | CYDEKIN, KIXTA, PALBOREST, PALNAT, PICICLIB |
| Capsules per Pack | 21 Capsules |
| Usage | Breast Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Bottle or Blister |
| Weight/bottle | 50gms |
Palbociclib 100 mg Tablet is a CDK4/6 inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer, used in combination with endocrine therapy. It helps inhibit cancer cell division and disease progression. The product is available for export from WHO-GMP compliant manufacturing facilities, with COA and regulatory documentation available on request.
Keywords
Palbociclib Tablet
Palbociclib 100 mg
CDK4/6 Inhibitor Tablet
Breast Cancer Treatment Tablet
HR Positive Breast Cancer Drug
Targeted Oncology Tablet
Cancer Medicine Exporter
Anticancer Tablet
Additional Information:
Approx. Rs 1,099 / BottleGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 10 Bottle |
| Strength | 125 mg |
| Brand | PRIMCYV, CYDEKIN, PALBOREST, PALNAT, ISOGEN |
| Capsules per Pack | 21 Capsules |
| Usage | Breast Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Blister or Bottle |
| Weight/bottle | 50gms |
Palbociclib 125 mg Tablet is an oral CDK4/6 inhibitor used for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with hormonal therapy. It works by slowing cancer cell proliferation. This product is available for export and is manufactured in WHO-GMP compliant facilities. COA and required export documents are available on request.
Keywords
Palbociclib Tablet
Palbociclib 125 mg
CDK4/6 Inhibitor Medicine
Breast Cancer Oncology Tablet
Advanced Breast Cancer Drug
Targeted Therapy Tablet
Oncology Tablet Export
Anticancer Oral Drug
Additional Information:
Approx. Rs 8,000 / VialGet Latest Price
Product Details:| Dosage Form | Lyophilized Powder for Injection |
| Treatment | HER2-Positive Cancers |
| Packaging Type | Multi-Use Vial |
| Brand | ELEFTHA, HERTRAZ, VIVITRA, TRASTUREL, HERMAB, TRUMAB |
| Manufacturer | (ELEFTHA, HERTRAZ, VIVITRA, TRASTUREL, HERMAB, TRUMAB) |
| Strength | 440 mg |
| Drug Type | Biosimilar |
| Physical Form | Lyophilized Powder |
| Storage Temperature | 2-8 degree c |
| Composition | Trastuzumab |
Additional Information:
Approx. Rs 25,000 / VialGet Latest Price
Product Details:| Dosage Form | Injection |
| Treatment | HER2-Positive Cancers |
| Packaging Type | Single-Use Vial |
| Brand | Ujvira |
| Manufacturer | Zydus |
| Strength | 100 MG & 160 MG |
| Drug Type | Trastuzumab Emtansine |
| Physical Form | Lyophilized Powder |
| Storage Temperature | 2-8 degree c |
Trastuzumab Emtansine injection is a HER2-targeted antibody–drug conjugate used in the treatment of HER2-positive breast cancer. It requires strict cold-chain storage and controlled handling. Suitable for hospitals, oncology centers, and institutional supply, the product is available for export with complete documentation and global shipping support.
Keywords: Trastuzumab Emtansine Injection, T-DM1 Injection, HER2 Positive Breast Cancer Drug, Antibody Drug Conjugate, Oncology Injection, Targeted Cancer Therapy, Trastuzumab DM1, Breast Cancer Medicine, Cold Chain Oncology Product.
Additional Information:
Approx. Rs 3,000 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 10 Vial |
| Strength | 100 mg |
| Volume | 4 ml |
| Pharmaceutical Form | Concentrate |
| Brand | (BEVATAS, BRYXTA, AVASTIN, BEVACIREL) |
| Packaging Type | Vial |
| Storage Temperature | 2-8 degree c |
| Country Of Origin | India |
| Product Type | Biosimilar |
| Active Ingredient | Bevacizumab |
Bevacizumab 100 mg Injection is a recombinant humanized monoclonal antibody widely used in the treatment of various solid tumors. It works by inhibiting vascular endothelial growth factor (VEGF), thereby preventing the formation of new blood vessels that supply nutrients to cancer cells and slowing tumor growth. This targeted anti-angiogenic therapy is commonly prescribed as part of combination oncology regimens under specialist supervision.
Manufactured in WHO-GMP compliant facilities and supplied in accordance with international regulatory standards.
Keywords
Bevacizumab 100 mg Injection, Bevacizumab Injection, Anti-Cancer Injection, Oncology Injection Supplier, Monoclonal Antibody Injection, VEGF Inhibitor Injection, Anti-Angiogenic Cancer Drug, Bevacizumab Exporter India, Bevacizumab Supplier, Oncology Medicines Exporter, Cancer Injection Manufacturer, WHO-GMP Oncology Products, Bevacizumab 100 mg Vial, Targeted Cancer Therapy Injection, Pharmaceutical Exporter India
Additional Information:
Approx. Rs 7,500 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 10 Vial |
| Strength | 300 mg |
| Volume | 12 ml |
| Pharmaceutical Form | Concentrate |
| Brand | Bevatas |
| Packaging Type | Vial |
| Storage Temperature | 2-8 degree c |
| Country Of Origin | India |
| Product Type | Biosimilar |
| Active Ingredient | Bevacizumab |
Bevacizumab 300 mg Injection is a recombinant humanized monoclonal antibody used in the treatment of various solid malignancies. It acts by inhibiting vascular endothelial growth factor (VEGF), thereby preventing angiogenesis (formation of new blood vessels) and restricting tumor growth and metastasis.
It is commonly used as part of combination chemotherapy regimens under the supervision of an oncology specialist.
Manufactured in WHO-GMP compliant facilities and supplied as per international regulatory standards.
Keywords
Bevacizumab 300 mg Injection, Bevacizumab Injection 300 mg, Anti-Cancer Injection, Oncology Injection Supplier, Monoclonal Antibody Injection, VEGF Inhibitor Injection, Anti-Angiogenic Cancer Drug, Bevacizumab Exporter India, Bevacizumab Supplier, Oncology Medicines Exporter, Cancer Injection Manufacturer, WHO-GMP Oncology Products, Bevacizumab 300 mg Vial, Targeted Cancer Therapy Injection, Pharmaceutical Exporter India
Additional Information:
Approx. Rs 7,500 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 10 Vial |
| Strength | 400 mg |
| Volume | 16 ml |
| Pharmaceutical Form | Concentrate |
| Brand | (BEVATAS, VERSAVO, BEVACIREL, BRYXTA) |
| Packaging Type | Vial |
| Storage Temperature | 2-8 degree c |
| Country Of Origin | India |
| Product Type | Biosimilar |
| Active Ingredient | Bevacizumab |
Bevacizumab 400 mg Injection is a recombinant humanized monoclonal antibody indicated for the treatment of various solid tumors. It works by inhibiting vascular endothelial growth factor (VEGF), thereby blocking angiogenesis (new blood vessel formation) and limiting tumor growth and spread.
It is widely used in oncology treatment protocols, either alone or in combination with chemotherapy, under specialist supervision.
Manufactured in WHO-GMP compliant facilities and supplied as per international regulatory requirements.
Keywords
Bevacizumab 400 mg Injection, Bevacizumab Injection 400 mg, Anti-Cancer Injection, Oncology Injection Supplier, Monoclonal Antibody Injection, VEGF Inhibitor Injection, Anti-Angiogenic Cancer Drug, Bevacizumab Exporter India, Bevacizumab Supplier, Oncology Medicines Exporter, Cancer Injection Manufacturer, WHO-GMP Oncology Products, Bevacizumab 400 mg Vial, Targeted Cancer Therapy Injection, Pharmaceutical Exporter India
Additional Information:
Approx. Rs 19,000 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 5 Vial |
| Strength | 420 mg |
| Pack Size | 14 ml |
| Brand | SIGRIMA, WOMAB, INTAZUMAB, HER2-P |
| Manufacturer | INTAS |
| Concentration | 30 mg/ml |
| Formulation Type | Solution Concentrate |
| Storage Condition | 2-8 degree c |
| Composition | Pertuzumab |
Pertuzumab 420 mg Injection is a monoclonal antibody used in the treatment of HER2-positive breast cancer, commonly administered in combination with trastuzumab and chemotherapy. The injection is for intravenous use under medical supervision. This product is available for export and is sourced from WHO-GMP compliant manufacturing facilities. COA and regulatory documents are available on request, with cold-chain packaging ensured for safe international shipment.
Keywords
Pertuzumab Injection
Pertuzumab 420 mg
HER2 Breast Cancer Injection
Monoclonal Antibody Oncology Drug
Breast Cancer Biologic Injection
Targeted Cancer Therapy
HER2 Positive Cancer Medicine
Oncology Injectable Medicine
Anti HER2 Monoclonal Antibody
Cancer Treatment Injection
Additional Information:
Approx. Rs 1,399 / BoxGet Latest Price
Product Details:| Minimum Order Quantity | 5 Box |
| Strength | 150 mg |
| Brand | RIBAXA, BRACANAT, OLPAZA, BRACALOC |
| Tablets per Pack | 60 Tablets |
| Usage | Ovarian Cancer, Cancer Care |
| Form | Tablet |
| Pack Type | Bottle or blister |
| Composition | Olaparib |
Olaparib is a PARP inhibitor indicated for the treatment of certain advanced cancers associated with BRCA mutations. It works by blocking PARP enzymes involved in DNA repair, leading to cancer cell death.
We supply Indian brands suitable for regulated and semi-regulated markets. The product is available for merchant export with proper export documentation and timely shipment.
For pricing, lead time, and bulk requirements, please contact us directly.
Olaparib tablets exporter
Olaparib 150 mg supplier India
PARP inhibitor medicine
Anti cancer tablets India
Olaparib bulk supply
Oncology medicines exporter
Additional Information:
Approx. Rs 199 / PieceGet Latest Price
Product Details:| Minimum Order Quantity | 50 Piece |
| Strength | 300 mcg/ml |
| Molecule | Filgrastim |
| Packaging Type | PFS |
| Brand | Neukine |
| Route of Administration | SC Injection, IV Injection |
| Pack Size | Single PFS |
| Storage Temperature | 2–8°C |
| Usage | Pharmacy Trade, Hospital, Cancer Centre |
NEUKINE 300 contains Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF) used to stimulate neutrophil production. It is indicated for the management of chemotherapy-induced neutropenia, reduction of infection risk in cancer patients, and for use in bone marrow transplantation and severe chronic neutropenia.
This product is widely used in oncology and hospital settings and is suitable for export to regulated and semi-regulated markets, subject to country-specific requirements.
Filgrastim injection export, Neukine 300 supplier, G-CSF injection, neutropenia treatment drug, oncology supportive care medicine, cancer supportive injection, hospital injectables exporter, Intas Filgrastim
Additional Information:
Approx. Rs 520 / StripGet Latest Price
Product Details:| Minimum Order Quantity | 10 Strip |
| Composition | Upadacitinib |
| Strength | 15mg |
| Brand Name | TORRENT PHARMA |
| Packaging Size | 10 Tablets |
| Form | Tablet |
| Manufacturer | MSN Laboratories pvt ltd |
Upadacitinib (often marketed under the brand name Rinvoq) 15mg is an oral, extended-release, small-molecule medication used to treat various chronic inflammatory and autoimmune conditions. It is a selective Janus kinase (JAK) 1 inhibitor that reduces inflammation and immune system overactivity.
DrugBank +4
Product Description & Mechanism:
Active Ingredient: Upadacitinib (15mg per extended-release tablet).
Appearance: Typically purple, biconvex oblong tablets (14 x 8 mm) often debossed with "a15".
Mechanism of Action: Functions as a JAK1-selective inhibitor, blocking signaling pathways of inflammatory cytokines, which helps decrease inflammation, joint damage, and skin symptoms.
Indian Journal of Dermatology, Venereology and Leprology +3
Indications (15mg dose):
Rheumatoid Arthritis: Moderately to severely active in adults.
Psoriatic Arthritis: Active, in adults and children 2+.
Atopic Dermatitis (Eczema): Moderate to severe in adults and children 12+.
Ulcerative Colitis & Crohn's Disease: Moderate to severe (often as maintenance dose).
Ankylosing Spondylitis & Non-radiographic Axial Spondyloarthritis: Active, in adults.
Giant Cell Arteritis: In adults.
DailyMed (.gov) +4
Key Usage Guidelines:
Dosage: Generally 15 mg once daily, taken orally with or without food.
Administration: Tablets should be swallowed whole and not split, crushed, or chewed.
Warnings: It is an immunosuppressant and carries boxed warnings for serious infections, mortality, malignancy, major adverse cardiovascular events (MACE), and thrombosis
Approx. Rs 3,593 / BottleGet Latest Price
Product Details:| Minimum Order Quantity | 1 Bottle |
| Strength | 30 mg |
| Packaging Size | 30 Tablets |
| Manufactured By | MSN |
| Prescription/Non Prescription | Prescription |
| Country of Origin | Made in India |
Additional Information:
Approx. Rs 4,500 / BottleGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 1 Bottle |
| Packaging Size | Bottle |
| Brand | Lenalid 25Mg Capsule |
| Manufacturer | Natco Ltd |
| Composition | Lenalidomide |
| Treatment | cancer treatment |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Country of Origin | Made in India |
Additional Information:
Approx. Rs 200 / VialGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 5 Vial |
| Strength | 500000 IU |
| Usage/Application | Personal / Hospital |
| Brand | Hipoly B Inj |
| Drug Name | Polymixibin B Sulphate |
| Dose | 500000 UNits |
| Composition | Polymixin B Sulphate |
| Storage Condition | 25 to 30 Degree |
| Packaging Size | Box |
| Packaging Type | Vial |
| Country of Origin | Made in India |
Additional Information:
Approx. Rs 2,800 / BottleGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 1 Bottle |
| Strength | 10 mg |
| Manufacturer | Natco Ltd |
| Prescription/Non prescription | Prescription |
| Packaging Size | 30 Capsules |
| Medicine Type | Allopathic |
| Brand | Natco |
| Usage | Clinical and Hospital |
| Available Dose | 5,10,25 mg |
| Composition | Lenlidomide Capsules |
|
Product Name |
Company |
Strengths |
|
MMLINODA |
ALKEM LTD. |
10MG |
|
LENMID |
CIPLA LTD. |
25MG, 10MG & 5MG |
|
LENANGIO |
DR. REEDY’S |
25MG, 10MG & 5MG |
|
KABILEN |
FRESENIUS KABI |
25MG, 10MG & 5MG |
|
LENOME |
INTAS BIOPHARMACEUTICALS LTD. |
25MG, 10MG, 15MG & 5MG |
|
NEOLIMID |
NEON LAB LTD. |
25MG, 10MG & 5MG |
|
LENZEST |
SUN PHARMA LTD. |
25MG, 10MG & 5MG |
|
NOJETRO |
TORRENT |
25MG & 10MG |
Additional Information:
Approx. Rs 3,600 / BottleGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 1 Bottle |
| Strength | 10 mg |
| Manufacturer | emcure ltd |
| Packaging Size | 100 Capsules |
| Brand | Emcure |
| Medicine Type | Allopathic |
| Form Of Medicines | Capsules |
| Form | capsule |
| Prescription/Non prescription | Prescription |
| Packaging Type | Bottles |
| Certification | ISO |
| Usage | Clinic and Hospital |
| Composition | Tretinoin [All Trans Retinoic Acid] Soft Gelatin Capsules |
Additional Information:
Approx. Rs 4,000 / BottleGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 1 Bottle |
| Strength | 400+100MG |
| Dose/Strength | 400 mg/ 100 mg |
| Packaging Size | 28 TAB |
| Composition | SOFOSBUVIR 400MG & VELPATASVIR 100MG TAB |
| Treatment | Hepatitis C virus infection |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Brand | VELPANAT TAB |
| Manufacturer | Glenmark Pharmaceuticals |
| Shelf life | 24 MONTHS |
Additional Information:
Approx. Rs 1,800 / VialGet Latest Price
Product Details:| Strength | 200 mg |
| Injection Type | Lyophilized Powder |
| Composition | Gemcitabine IP |
| Packaging Size | 1 Vial |
| Brand | Gemtero |
| Route | IV |
| Usage | Pancreatic Ca |
| Form | Injection |
Approx. Rs 1,700 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 10 Vial |
| Strength | 100 mg |
| Vial Volume | 10 ml |
| Brand | MABTAS , REDITUX |
| Strength per ml | 10 mg/ml |
| Composition | Rituximab |
| Packaging Type | Vial |
| Indication | CLL, NHL |
| Route | IV Infusion |
| Storage Temp | 2–8°C |
Rituximab 100 mg injection is a monoclonal antibody used in the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and certain autoimmune disorders. Rituximab works by targeting the CD20 antigen present on B-lymphocytes, leading to their destruction and helping control abnormal immune responses and cancer cell proliferation. This injection is widely used in oncology, immunology, and hematology settings and is administered under medical supervision in hospital environments.
Keywords:
Rituximab injection, Rituximab 100 mg, anti CD20 monoclonal antibody, lymphoma treatment injection, CLL injection, rheumatoid arthritis biologic, oncology injectable medicine, hospital supply rituximab, cancer therapy injection, immunotherapy drug
Additional Information:
Approx. Rs 7,000 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 10 Vial |
| Strength | 500 mg |
| Vial Volume | 50 ml |
| Brand | MABTAS , REDITUX |
| Strength per ml | 10 mg/ml |
| Composition | Rituximab |
| Packaging Type | Vial |
| Indication | NHL, CLL |
| Route | IV Infusion |
| Storage Temp | 2–8°C |
Rituximab 500 mg injection is a monoclonal antibody indicated for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and other autoimmune conditions. It selectively binds to the CD20 antigen on B-cells, resulting in B-cell depletion and suppression of disease progression. Rituximab 500 mg injection is commonly used in oncology and immunotherapy protocols and is administered intravenously under strict medical supervision.
Keywords:
Rituximab injection, Rituximab 500 mg, monoclonal antibody injection, CD20 antibody, cancer immunotherapy drug, lymphoma injectable medicine, CLL treatment injection, biologic injection supplier, hospital oncology medicine
Additional Information:
Approx. Rs 17,099 / BoxGet Latest Price
Product Details:| Minimum Order Quantity | 5 Box |
| Packaging Size | 14 tablets |
| Tablets per Pack | 14 Tablets |
| Brand | Ramiven |
| Composition | Abemaciclib |
| Manufacturer | Eli Lilly |
| Form | Film Coated Tablet |
| Indication | HR+ HER2- Cancer, Breast Cancer, Metastatic Cancer |
| Country of Origin | USA |
| Strength | 50mg, 100mg, 150mg, 200mg |
RAMIVEN contains Abemaciclib, a targeted CDK4/6 inhibitor used in the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer. It is widely prescribed as monotherapy or in combination with endocrine therapy to help inhibit cancer cell proliferation and improve progression-free survival.
This product is suitable for regulated and semi-regulated export markets, subject to country-specific requirements.
Abemaciclib tablets export, RAMIVEN Abemaciclib supplier, CDK4/6 inhibitor medicine, breast cancer drug exporter, oncology tablets India, anticancer medicine export, Lilly Abemaciclib brand, hospital oncology drugs
Additional Information:
Approx. Rs 2,499 / BoxGet Latest Price
Product Details:| Minimum Order Quantity | 5 Box |
| Strength | 4 mg |
| Brand | LENTYKINE |
| Capsules per Pack | 30 Capsules |
| Usage | Cancer Care, Renal Cancer, Thyroid Cancer, Liver Cancer |
| Form | Capsule |
| Pack Type | Blister |
| Certificates | COA & GMP |
LENTYKINE 4 contains Lenvatinib, an oral multi-kinase inhibitor used in the treatment of advanced cancers, including differentiated thyroid cancer (DTC), hepatocellular carcinoma (HCC), and renal cell carcinoma (in combination therapy), as per approved indications.
It works by inhibiting multiple receptor tyrosine kinases involved in tumor angiogenesis and tumor cell proliferation, making it a key targeted therapy in modern oncology practice. The product is suitable for supply to institutional buyers, hospitals, and oncology distributors for export markets.
Lenvatinib 4 mg export, Lentykine capsules supplier, targeted cancer therapy, oral oncology medicine, thyroid cancer drug, HCC treatment medicine, oncology capsules exporter, anticancer drugs India
Additional Information:
Approx. Rs 3,099 / BoxGet Latest Price
Product Details:| Minimum Order Quantity | 10 Box |
| Strength | 80 mg |
| Dosage Form | Capsule |
| Brand | Enzamide |
| Units per Pack | 14 Units |
| Usage | Cancer Care, Prostate Cancer |
| Pack Type | Strip |
| Certificates | COA & GMP |
Enzalutamide 80 mg is an advanced oral androgen receptor inhibitor used in the treatment of prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic CRPC, as per approved indications.
It works by inhibiting androgen receptor signaling at multiple steps, thereby suppressing tumor growth and disease progression. The product is widely used in oncology practice and is suitable for export to regulated and semi-regulated markets.
Enzalutamide 80 mg export, prostate cancer medicine, androgen receptor inhibitor, oral oncology capsules, anticancer drugs supplier India, CRPC treatment drug, oncology exporter
Additional Information:
Approx. Rs 3,199 / BoxGet Latest Price
Product Details:| Minimum Order Quantity | 10 Box |
| Strength | 160 mg |
| Dosage Form | Tablet |
| Brand | ENZAMIDE, SAMENZA, GLENZA |
| Units per Pack | 7 Units |
| Usage | Prostate Cancer, Cancer Care |
| Pack Type | Strip |
| Certificates | COA & GMP |
Enzalutamide 160 mg is a high-strength oral androgen receptor inhibitor indicated for the treatment of prostate cancer, including metastatic and non-metastatic castration-resistant prostate cancer (CRPC), as per approved clinical use.
The drug blocks androgen receptor signaling at multiple stages, helping to slow disease progression and improve clinical outcomes. This strength is commonly prescribed as a once-daily regimen and is widely demanded in international oncology markets.
Enzalutamide 160 mg export, prostate cancer treatment drug, androgen receptor blocker, oncology capsules supplier India, CRPC medicine exporter, anticancer oral therapy
Additional Information:
Approx. Rs 6,999 / BottleGet Latest Price
Product Details:| Minimum Order Quantity | 10 Bottle |
| Brand | ABIONE, ABIRATRED |
| Tablets per Pack | 60 Tablets |
| Pack Type | Box |
| Usage | Prostate Cancer, Cancer Care |
| Form | Tablet |
| Release Type | Uncoated |
| Strength | 250mg, 500mg |
Additional Information:
Approx. Rs 999 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 10 Vial |
| Dosage Form | Injection |
| Manufacturer | INTAS, NATCO, DR REDDY |
| Treatment | Myelodysplastic Syndrome |
| Dose Strength | 100 mg |
| Storage Condition | Store Below 25 Degree C |
| Usage/Application | Hospital |
| Composition | Azacitidine |
Additional Information:
Approx. Rs 3,999 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 10 Vial |
| Dosage Form | Lyophilized Powder |
| Treatment | Myelodysplastic Syndrome |
| Manufacturer | Intas Pharmaceuticals |
| Dose Strength | 150 mg |
| Storage Condition | Store in Refrigerator (2 to 8 Degree C) |
| Usage/Application | Hospital |
| Brand | Azadine |
| Composition | Azacitidine |
Additional Information:
Approx. Rs 199 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 100 Vial |
| Formulation Type | Conventional |
| Brand | TAXELEON, CYTAX, INTAXEL, DUTAXEL |
| Pharmacopoeia Standard | IP |
| Strength | 30 mg |
| Packaging Size | 5 ml |
| Shelf Life | 24 months |
| Storage Temperature | 20-25 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
Additional Information:
Approx. Rs 269 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 100 Vial |
| Formulation Type | Conventional |
| Brand | CYTAX, MITOTAX, DUTAXEL |
| Pharmacopoeia Standard | IP |
| Strength | 100 mg |
| Packaging Size | 16.7 ml |
| Shelf Life | 24 months |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
Additional Information:
Approx. Rs 999 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 50 Vial |
| Formulation Type | Conventional |
| Brand | CYTAX, DUTAXEL, INTAXEL, TAXELEON |
| Pharmacopoeia Standard | IP |
| Strength | 260 mg |
| Packaging Size | 43.3 ml |
| Shelf Life | 24 months |
| Storage Temperature | 20-25 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
Additional Information:
Approx. Rs 1,899 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 50 Vial |
| Formulation Type | Conventional |
| Brand | CYTAX, MITOTAX, TAXELEON |
| Pharmacopoeia Standard | IP |
| Packaging Size | 50 ml |
| Shelf Life | 24 months |
| Storage Temperature | 20-25 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
| Strength | 100 mg |
Additional Information:
Approx. Rs 790 / BottleGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 2 Bottle |
| Strength | 10 mg |
| Manufacturer | Glenmark ltd |
| Prescription/Non prescription | Prescription |
| Packaging Size | 10 Capsules |
| Form Of Medicines | Capsules |
| Brand | Dr.Reddy's |
| Type of Medicines | Allopathic |
| Composition | Lenalidomide Capsules |
| Available Dose | 5,10,25 mg |
Additional Information:
Approx. Rs 300 / PieceGet Latest Price
Product Details:| Minimum Order Quantity | 5 Piece |
| Strength | 5000iu |
| Medicine Type | Injection |
| Brand | Sun Pharma Ltd |
| Usage/Application | Clinical |
| Composition | Chorionic Gonadotrophin |
| Injectable Form | Lyophilized Powder |
| Dose | 5000iu |
| Product Type | Finished Product |
| Gender | Unisex |
| Country of Origin | Made in India |
Additional Information:
Approx. Rs 7,995 / VialGet Latest Price
Product Details:| Minimum Order Quantity | 1 Vial |
| Strength | 100 mg |
| Vial Volume | 20 ml |
| Brand | Lupitux 100 |
Additional Information:
Approx. Rs 7,000 / BoxGet Latest Price
Product Details:| Minimum Order Quantity | 1 Box |
| Strength | 15 mg/ 6.14 mg |
| Manufacture By | Natco Ltd |
| Packing Type | Bottle |
| Storage Instructions | 25 to 30 degree |
| Manufactured By | Natco Ltd |
| Item Name | Tipanat 15mg/20mg tablet |
| Product Name | Tipanat 15mg/20mg tablet |
| Drug Name | Trifluridine & Tipiracil |
| Dose Strength | 15MG/20MG |
Additional Information:
Approx. Rs 350 / StripeGet Latest Price
Product Details:| Minimum Order Quantity | 10 Stripe |
| Pirfenidone Strength | 200 mg |
| Dose/Strength | 200Mg |
| Dose Form | Tablet |
| Indication | Idiopathic Pulmonary Fibrosis |
| Packaging Size | Strip of tab |
| Usage/Application | Personal |
| Strength | 200Mg |
| Brand | Pirfenex 200Mg Tab |
| Composition | Pirfenidone |
| Company | Cipla |
| Active Ingredient | Pirfenidone |
| Packaging Type | Box |
| Country of Origin | Made in India |
Additional Information:
Approx. Rs 9,000 / BottleGet Latest Price
Product Details:| Minimum Order Quantity | 1 Bottle |
| Strength | 500 mg |
| Form | Tablet |
| Packaging Size | Bottle |
| Manufacturer | BDR LTD |
| Prescription/Non prescription | Prescription |
| Composition | Abiraterone Acetate |
| Brand | BDRON 500MG TAB |
| Treatment | Cancer Treatment |
| Country of Origin | Made in India |
Additional Information:
Approx. Rs 6,500 / BottleGet Latest Price
Product Details:| Minimum Order Quantity | 1 Bottle |
| Packaging size | Bottle |
| Brand | Abirapro 250MG tab |
| Composition | Abiraterone Acetate |
| Manufacturer | Glenmark |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Shelf life | 25 Months |
| Strength | 250Mg |
| Manufactured By | Glenmark Ltd |
| Minimum Order Quantity | 1 |
| Drug Name | Abiraterone Acetate |
| Generic | Abiraterone Acetate |
| Country of Origin | Made in India |
Additional Information:
Explore More Products
© D. Vijay Pharma Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited